Saved in:
| Main Authors: | Sud, Anvi, Huang, Jialu, Hart, Gregory R., Saxena, Keshav, Kim, John, Tressel, Lauren, Deng, Jun |
|---|---|
| Format: | Preprint |
| Published: |
2026
|
| Subjects: | |
| Online Access: | https://arxiv.org/abs/2602.18496 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
Chemoimmunotherapy With or Without Thoracic Radiotherapy for Elderly Patients in Advanced Non‐Small Cell Lung Cancer
by: Zhiru Gao, et al.
Published: (2026)
by: Zhiru Gao, et al.
Published: (2026)
Combination Immunotherapy With Radiotherapy in Non‐Small Cell Lung Cancer: A Review of Evidence
by: Justin L. Burr, et al.
Published: (2024)
by: Justin L. Burr, et al.
Published: (2024)
Plasma Lipidomics Profiling to Identify the Biomarkers of Diagnosis and Radiotherapy Response for Advanced Non-Small-Cell Lung Cancer Patients
by: Minghe Lv, et al.
Published: (2024)
by: Minghe Lv, et al.
Published: (2024)
The Optimal Radiotherapy Strategy for Patients With Small Cell Lung Cancer and Brain Metastasis: A Retrospective Analysis
by: Qian Zeng, et al.
Published: (2024)
by: Qian Zeng, et al.
Published: (2024)
A Digital Twin Framework for Adaptive Treatment Planning in Radiotherapy
by: Chang, Chih-Wei, et al.
Published: (2025)
by: Chang, Chih-Wei, et al.
Published: (2025)
Survival in Immune Checkpoint Inhibitor–Treated Patients With Rheumatoid Arthritis and Non–Small Cell Lung Cancer: An Observational Cohort Study
by: Deanna P. Jannat‐Khah, et al.
Published: (2025)
by: Deanna P. Jannat‐Khah, et al.
Published: (2025)
ASPM Induces Radiotherapy Resistance by Disrupting Microtubule Stability Leading to Chromosome Malsegregation in Non‐Small Cell Lung Cancer
by: Tao Zhong, et al.
Published: (2025)
by: Tao Zhong, et al.
Published: (2025)
Predictive Digital Twin for Optimizing Patient-Specific Radiotherapy Regimens under Uncertainty in High-Grade Gliomas
by: Chaudhuri, Anirban, et al.
Published: (2023)
by: Chaudhuri, Anirban, et al.
Published: (2023)
Long‐Term Outcomes and Toxicities in Patients With Metastatic Non‐Small Cell Lung Cancer Treated With Immunotherapy Containing Regimens
by: Meghana Maddula, et al.
Published: (2025)
by: Meghana Maddula, et al.
Published: (2025)
Programmed Death‐Ligand 1 Expression Predicts Poor Prognosis in Patients With Early‐Stage Non‐Small‐Cell Lung Cancer Undergoing Stereotactic Body Radiotherapy
by: Jongmoo Park, et al.
Published: (2026)
by: Jongmoo Park, et al.
Published: (2026)
Expression of NUF2 and CD52 and Their Correlation With Chemotherapy Resistance and Prognosis in Patients With Non‐Small Cell Lung Cancer
by: Jun Han, et al.
Published: (2025)
by: Jun Han, et al.
Published: (2025)
Pembrolizumab‐Induced Chronic Rhinosinusitis in a Patient With Non‐Small Cell Lung Cancer
by: Yuji Yamasaki, et al.
Published: (2025)
by: Yuji Yamasaki, et al.
Published: (2025)
Comparison of Survival Outcomes of Early‐Stage Non‐Small‐Cell Lung Cancer in Elderly Patients (≥ 70 years) Treated With Stereotactic Body Radiotherapy Versus Surgical Resection
by: Guo‐jun Wu, et al.
Published: (2025)
by: Guo‐jun Wu, et al.
Published: (2025)
Population Pharmacokinetics and Exposure‐Response of Subcutaneous Atezolizumab in Patients With Non‐Small Cell Lung Cancer
by: Phyllis Chan, et al.
Published: (2025)
by: Phyllis Chan, et al.
Published: (2025)
Drug Interaction Between Erlotinib and Itraconazole in a Patient With Non–Small Cell Lung Cancer
by: Hayato Yokota, et al.
Published: (2026)
by: Hayato Yokota, et al.
Published: (2026)
The Efficacy and Safety of Brain Radiotherapy Combined With Immune Checkpoint Inhibitors (ICIs) for Small‐Cell Lung Cancer (SCLC) Patients With Brain Metastases (BMs)
by: Jie Xu, et al.
Published: (2025)
by: Jie Xu, et al.
Published: (2025)
The Efficacy of Anlotinib Plus Whole Brain Radiotherapy in Advanced Non‐Small Cell Lung Cancer With Multiple Brain Metastases: A Retrospective Study
by: Lipin Liu, et al.
Published: (2024)
by: Lipin Liu, et al.
Published: (2024)
FOXA1‐NAT10 Positive Feedback Pathway Promotes Non‐Small Cell Lung Cancer Cell Progression
by: Anqing Zhu, et al.
Published: (2025)
by: Anqing Zhu, et al.
Published: (2025)
Advances and Future Perspectives for the Management of Non‐Small Cell Lung Cancer in Australia: A Narrative Review
by: Lauren Julia Brown, et al.
Published: (2025)
by: Lauren Julia Brown, et al.
Published: (2025)
Chromosomal Instability Identifies High‐Risk Patients With Early‐Stage Non‐Small Cell Lung Cancer
by: Mobina Shrestha, et al.
Published: (2026)
by: Mobina Shrestha, et al.
Published: (2026)
Cutaneous Toxicities Associated With Amivantamab in Patients With Non‐Small Cell Lung Cancer: A Systematic Review
by: Ioannis‐Alexios Koumprentziotis, et al.
Published: (2026)
by: Ioannis‐Alexios Koumprentziotis, et al.
Published: (2026)
Tepotinib‐Induced Cholangitis in a Patient With Non‐Small Cell Lung Cancer: A Case Report
by: Yoshimasa Hachisu, et al.
Published: (2025)
by: Yoshimasa Hachisu, et al.
Published: (2025)
Association Between Area‐Level Socioeconomic Disadvantage and Immunotherapy in Patients With Non‐Small Cell Lung Cancer
by: Hiroe Suzuki‐Chiba, et al.
Published: (2025)
by: Hiroe Suzuki‐Chiba, et al.
Published: (2025)
Effectiveness of Perioperative Radiotherapy With Systemic Therapy on Survival of Squamous Cell Lung Cancer Patients With Pathologic N2
by: Yongzheng Yao, et al.
Published: (2025)
by: Yongzheng Yao, et al.
Published: (2025)
Automatic Cough Analysis for Non-Small Cell Lung Cancer Detection
by: Giangregorio, Chiara, et al.
Published: (2025)
by: Giangregorio, Chiara, et al.
Published: (2025)
Mediators of Racial Inequities in Non‐Small Cell Lung Cancer Care
by: Safraz A. Hamid, et al.
Published: (2025)
by: Safraz A. Hamid, et al.
Published: (2025)
Pseudocellulitis in the Setting of Pemetrexed Treatment for Non‐Small Cell Lung Cancer
by: Cassidy M. Nguyen, et al.
Published: (2025)
by: Cassidy M. Nguyen, et al.
Published: (2025)
Nanomedicine in Immunotherapy for Non‐Small Cell Lung Cancer: Applications and Perspectives
by: Shuangsi Liao, et al.
Published: (2025)
by: Shuangsi Liao, et al.
Published: (2025)
Ultrasound‐Responsive Lipid Nanoparticles for Targeted Therapy and Controlled Drug Release in Non‐Small Cell Lung Cancer
by: Min Woo Kim, et al.
Published: (2024)
by: Min Woo Kim, et al.
Published: (2024)
Predicting Targeted Therapy Resistance in Non-Small Cell Lung Cancer Using Multimodal Machine Learning
by: Hua, Peiying, et al.
Published: (2025)
by: Hua, Peiying, et al.
Published: (2025)
Integrative Analysis of Cuproptosis‐Related Mitochondrial Depolarisation Genes for Prognostic Prediction in Non‐Small Cell Lung Cancer
by: Guoqing Lyu, et al.
Published: (2025)
by: Guoqing Lyu, et al.
Published: (2025)
NFAT5 Regulates IL8 to Promote Cell Growth and Migration in Non‐Small Cell Lung Cancer
by: Jinliang Chen, et al.
Published: (2025)
by: Jinliang Chen, et al.
Published: (2025)
Efficacy of Osimertinib in Patients With Postoperative Recurrent Non–Small‐Cell Lung Cancer Harboring Sensitizing EGFR Mutations
by: Yuko Iida, et al.
Published: (2026)
by: Yuko Iida, et al.
Published: (2026)
Best Practices for the Multidisciplinary Care of Patients With Early‐Stage Driver‐Mutated Non‐Small Cell Lung Cancer
by: Joshua Sabari, et al.
Published: (2026)
by: Joshua Sabari, et al.
Published: (2026)
Desensitizing Effect of Intra‐Tumoral GDF‐15 on Immunotherapy in Patients With Advanced Non‐Small Cell Lung Cancer
by: Naoya Nishioka, et al.
Published: (2025)
by: Naoya Nishioka, et al.
Published: (2025)
Racotumomab in Non-Small Cell Lung Cancer as Maintenance and Second-Line Treatment
by: Haslen H. Cáceres-Lavernia
Published: (2021)
by: Haslen H. Cáceres-Lavernia
Published: (2021)
Pleuritis Induced by Brigatinib During the Treatment of Non‐Small Cell Lung Cancer
by: Shohei Yano, et al.
Published: (2026)
by: Shohei Yano, et al.
Published: (2026)
Pyroptosis‐Mediated Antitumor Activity of Cinobufagin in Non‐Small Cell Lung Cancer
by: Ying Chen, et al.
Published: (2025)
by: Ying Chen, et al.
Published: (2025)
Is Chest Wall Resection Safe in Geriatric Non‐Small Cell Lung Cancer?
by: Ozkan Saydam, et al.
Published: (2025)
by: Ozkan Saydam, et al.
Published: (2025)
Chronological Effects of Immune Checkpoint Inhibitors in Non‐Small Cell Lung Cancer
by: Xinyue Guo, et al.
Published: (2025)
by: Xinyue Guo, et al.
Published: (2025)
Similar Items
-
Chemoimmunotherapy With or Without Thoracic Radiotherapy for Elderly Patients in Advanced Non‐Small Cell Lung Cancer
by: Zhiru Gao, et al.
Published: (2026) -
Combination Immunotherapy With Radiotherapy in Non‐Small Cell Lung Cancer: A Review of Evidence
by: Justin L. Burr, et al.
Published: (2024) -
Plasma Lipidomics Profiling to Identify the Biomarkers of Diagnosis and Radiotherapy Response for Advanced Non-Small-Cell Lung Cancer Patients
by: Minghe Lv, et al.
Published: (2024) -
The Optimal Radiotherapy Strategy for Patients With Small Cell Lung Cancer and Brain Metastasis: A Retrospective Analysis
by: Qian Zeng, et al.
Published: (2024) -
A Digital Twin Framework for Adaptive Treatment Planning in Radiotherapy
by: Chang, Chih-Wei, et al.
Published: (2025)